Ambuan, Feldora D.

HRN: 21-65-91  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/01/2022
CEFUROXIME 500MG (TAB)
08/01/2022
08/08/2022
ORAL
500mg
BID
UTI
Waiting Final Action 

Indication:  EmpiricEmpirical De-escalation    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: